instructions): The Administrative Core provides the strategic direction, leadership, organizational structure, communications, oversight and support needed to fulfill the goals of the statewide Arizona Alzheimer's Disease Core Center (ADCC). It promotes the continued development and productive utilization of our Cores and Ancillary Research Programs. It fosters close working relationships among each of our Cores, our Ancillary Research Programs, and Investigators from a wide range of scientific disciplines and institutions in Arizona. It administers our statewide program for the solicitation, competitive review, support and monitoring of ADCC and locally supported pilot studies. It works closely with the National Alzheimer's Coordinating Center (NACC) and the National Institute on Aging (NIA), and supports collaborations with other ADCs and research programs inside and outside Arizona. It receives annual visits, feedback, advice and written reports from our External Advisory Committee. The Administrative Core provides the bridge between our ADCC and our locally supported Arizona Alzheimer's Research Center (AARC), which have complementary, non-overlapping, and mutually supportive roles in the Arizona Alzheimer's Consortium (AAC). Locally, our leaders and their colleagues work closely with the Alzheimer's Association Desert Southwest Chapter, leaders in Arizona's Native American and Latino communities, leading officials from each of our organizations and the state, and our other community partners. Nationally and Internationally, they continue to play important roles In the development of new research initiatives and collaborations, public policies in AD research and care, cognitive aging research, and outreach to some of our most underserved minority communities. They continue to identify, capitalize on, and try to fulfill unique scientific and organizational challenges, and to anticipate and address these unique challenges in association with a statewide, multi-institutional research program. They also continue to capitalize on the organization's particular interests, resources, and strengths in pursuit of their ambitious goals. They continue to secure an extraordinary level of local support, even during this financially challenging time, and they continue to have an extraordinary impact on AD research, care, and services in Arizona.

Public Health Relevance

The Arizona Alzheimer's Disease Center's Administrative Core provides the leadership needed to fulfill the goals of the Center. It continues to develop and use its statewide scientific resources in the most impactful collaborative, and accountable way. It is intended to make potentially transformational differences in the scientific fight against Alzheimer's disease.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
5P30AG019610-12
Application #
8379346
Study Section
Special Emphasis Panel (ZAG1-ZIJ-5)
Project Start
Project End
Budget Start
2012-07-01
Budget End
2013-06-30
Support Year
12
Fiscal Year
2012
Total Cost
$289,800
Indirect Cost
$105,168
Name
Banner Sun Health Research Institute
Department
Type
DUNS #
960181055
City
Sun City
State
AZ
Country
United States
Zip Code
85351
Mehta, Dev; Jackson, Robert; Paul, Gaurav et al. (2017) Why do trials for Alzheimer's disease drugs keep failing? A discontinued drug perspective for 2010-2015. Expert Opin Investig Drugs 26:735-739
Alosco, Michael L; Duskin, Jonathan; Besser, Lilah M et al. (2017) Modeling the Relationships Among Late-Life Body Mass Index, Cerebrovascular Disease, and Alzheimer's Disease Neuropathology in an Autopsy Sample of 1,421 Subjects from the National Alzheimer's Coordinating Center Data Set. J Alzheimers Dis 57:953-968
Sabbagh, M N (2017) Clinical Effects of Oral Tramiprosate in APOE4/4 Homozygous Patients with Mild Alzheimer's Disease Suggest Disease Modification. J Prev Alzheimers Dis 4:136-137
Pandya, Seema Y; Lacritz, Laura H; Weiner, Myron F et al. (2017) Predictors of Reversion from Mild Cognitive Impairment to Normal Cognition. Dement Geriatr Cogn Disord 43:204-214
Burke, Shanna L; O'Driscoll, Janice; Alcide, Amary et al. (2017) Moderating risk of Alzheimer's disease through the use of anxiolytic agents. Int J Geriatr Psychiatry 32:1312-1321
Jun, Gyungah R; Chung, Jaeyoon; Mez, Jesse et al. (2017) Transethnic genome-wide scan identifies novel Alzheimer's disease loci. Alzheimers Dement 13:727-738
Valera, Elvira; Spencer, Brian; Mott, Jennifer et al. (2017) MicroRNA-101 Modulates Autophagy and Oligodendroglial Alpha-Synuclein Accumulation in Multiple System Atrophy. Front Mol Neurosci 10:329
Soreq, Lilach; UK Brain Expression Consortium; North American Brain Expression Consortium et al. (2017) Major Shifts in Glial Regional Identity Are a Transcriptional Hallmark of Human Brain Aging. Cell Rep 18:557-570
Sun, Miao; Zhang, Huaye (2017) Par3 and aPKC regulate BACE1 endosome-to-TGN trafficking through PACS1. Neurobiol Aging 60:129-140
Smith, Kyle B; Kang, Paul; Sabbagh, Marwan N et al. (2017) The Effect of Statins on Rate of Cognitive Decline in Mild Cognitive Impairment. Alzheimers Dement (N Y) 3:149-156

Showing the most recent 10 out of 695 publications